Almoosa Health Company (TADAWUL:4018)

Saudi Arabia · Delayed Price · Currency is SAR

116.20

-1.50 (-1.27%)

Aug 13, 2026, 3:16 PM AST

-31.93% (1Y)

Market Cap	5.19B -32.9%
Revenue (ttm)	1.50B +14.1%
Net Income	163.40M -5.0%
EPS	3.69 -15.3%
Shares Out	44.30M
PE Ratio	31.75
Forward PE	23.19
Dividend	1.40 (1.20%)
Ex-Dividend Date	Aug 16, 2026

Volume	14,356
Open	116.20
Previous Close	117.70
Day's Range	116.20 - 116.20
52-Week Range	110.00 - 212.00
Beta	n/a
Analysts	Hold
Price Target	143.47 (+23.47%)
Earnings Date	Nov 3, 2026

About Almoosa Health Company

Almoosa Health Company operates as a private healthcare provider in the Kingdom of Saudi Arabia. It stores medical items and sells medicine, cosmetics, and disposable medical items. The company also operates specialist and rehabilitation hospitals, medical and emergency centers, pharmacies, mental health clinics, and oncology centers, as well as a college of health sciences. Its medical specialties include pain management, lymphatic massage, hyperbaric oxygen therapy, occupational therapy, speech and language disorders, personality and behavior... [Read more]

Industry Medical Care Facilities

Sector Healthcare

Founded 1996

Employees 2,884

Stock Exchange Saudi Stock Exchange

Ticker Symbol 4018

Full Company Profile

Financial Performance

In 2025, Almoosa Health Company's revenue was 1.42 billion, an increase of 17.79% compared to the previous year's 1.20 billion. Earnings were 236.54 million, an increase of 379.28%.

Financial Statements

Analyst Summary

According to 4 analysts, the average rating for 4018 stock is "Hold." The 12-month stock price target is SAR 143.47, which is an increase of 23.47% from the latest price.

Price Target

SAR 143.47

(23.47% upside)

Analyst Consensus: Hold

Stock Forecasts